VERMILLION, INC. Contracts & Agreements

At The Market Offering Agreement between Aspira Womens Health Inc. and H.C. Wainwright & Co., LLC dated August 2, 2024 (Filed With SEC on August 2, 2024)

Form of Warrant (Filed With SEC on July 31, 2024)

Form of Warrant Inducement Agreement (Filed With SEC on July 31, 2024)

Form of Common Warrant (Filed With SEC on July 2, 2024)

Form of Securities Purchase Agreement (Filed With SEC on July 2, 2024)

SECOND AMENDMENT TO Employment Agreement (Filed With SEC on June 27, 2024)

Second Amendment to Employment Agreement between Aspira Women's Health Inc. and Torsten Hombeck, dated June 6, 2024 (Filed With SEC on June 7, 2024)

Description of Aspira Women's Health Inc.'s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 1, 2024)

Amendment No. 5 to Testing and Services Agreement, executed as of December 6, 2022 by and among Aspira Womens Health Inc., Aspira Labs, Inc. and Quest Diagnostics Incorporated (Filed With SEC on April 1, 2024)

License Agreement between Aspira Womens Health Inc. and Dana-Farber Cancer Institute, Inc. effective March 20, 2023 (Filed With SEC on April 1, 2024)

First Amendment to Employment Agreement between Aspira Womens Health Inc. and Torsten Hombeck, dated March 20, 2024 (Filed With SEC on March 25, 2024)

Employment Agreement between Aspira Womens Health Inc. and Sandra Milligan effective April 1, 2024 (Filed With SEC on March 21, 2024)

Placement Agency Agreement dated January 24, 2024, by and between Aspira Womens Health Inc. and A.G.P./Alliance Global Partners (Filed With SEC on January 26, 2024)

Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on January 26, 2024)

Form of Warrant to Purchase Common Stock (Filed With SEC on January 26, 2024)

Form of Warrant Amendment to Common Stock Purchase Warrant (Filed With SEC on January 26, 2024)

Form of Securities Purchase Agreement, dated January 24, 2024, by and between Aspira Womens Health Inc. and the purchasers party thereto (Filed With SEC on January 26, 2024)

Placement Agency Agreement dated January 24, 2024, by and between Aspira Womens Health Inc. and A.G.P./Alliance Global Partners (Filed With SEC on January 25, 2024)

Form of Pre-Funded Warrant to Purchase Common Stock (Filed With SEC on January 25, 2024)

Form of Warrant to Purchase Common Stock (Filed With SEC on January 25, 2024)

Form of Warrant Amendment to Common Stock Purchase Warrant (Filed With SEC on January 25, 2024)

Form of Securities Purchase Agreement, dated January 24, 2024, by and between Aspira Womens Health Inc. and the purchasers party thereto (Filed With SEC on January 25, 2024)

Amended Consulting Agreement between Aspira Womens Health Inc. and NuPath, LLC (Filed With SEC on September 12, 2023)

Securities Purchase Agreement, dated July 20, 2023, by and between Aspira Womens Health Inc. and the Purchasers (Filed With SEC on July 24, 2023)

EMPLOYMENT AGREEMENT (Filed With SEC on May 16, 2023)

Amended and Restated Employment Agreement between Aspira Womens Health Inc. and Minh Merchant, effective March 28, 2023 (Filed With SEC on March 30, 2023)

Employment Agreement between Aspira Womens Health Inc. and Dr. Ryan Phan, effective May 3, 2022 (Filed With SEC on March 30, 2023)

Purchase Agreement, dated as of March 28, 2023, by and between Aspira Womens Health Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 30, 2023)

Registration Rights Agreement, dated as of March 28, 2023, by and between Aspira Womens Health Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 30, 2023)

Amended and Restated Employment Agreement between Aspira Womens Health Inc. and Nicole Sandford effective March 1, 2023 (Filed With SEC on March 2, 2023)

Sales Agreement, dated February 10, 2023 (Filed With SEC on February 10, 2023)

EMPLOYMENT AGREEMENT (Filed With SEC on November 30, 2022)

First Amendment to Employment Agreement between Aspira Womens Health Inc. and Robert Beechey dated September 20, 2022 (Filed With SEC on November 10, 2022)

Separation Agreement and Release between Aspira Womens Health Inc. and Robert Beechey dated November 10, 2022 (Filed With SEC on November 10, 2022)

Consulting Agreement between Aspira Womens Health Inc. and Robert Beechey dated November 10, 2022 (Filed With SEC on November 10, 2022)

Underwriting Agreement, dated as of August 22, 2022, by and between Aspira Womens Health Inc. and William Blair & Company, L.L.C (Filed With SEC on August 24, 2022)

Form of Warrant (Filed With SEC on August 24, 2022)

Form of Vermillion, Inc. Stock Option Award Agreement (Filed With SEC on August 10, 2022)

Form of Vermillion, Inc. Restricted Stock Award Agreement (Filed With SEC on August 10, 2022)

Aspira Womens Health Inc. 2019 Stock Incentive Plan (Filed With SEC on August 10, 2022)

Form of Aspira Womens Health Inc. Stock Option Award Agreement (Filed With SEC on August 10, 2022)

Form of Aspira Womens Health Inc. Restricted Stock Award Agreement (Filed With SEC on August 10, 2022)

Form of Vermillion, Inc. Stock Option Award Agreement (non-employee) (Filed With SEC on August 10, 2022)

Form of Aspira Womens Health Inc. Stock Option Award Agreement (non-employee) (Filed With SEC on August 10, 2022)

Description of Aspira Women's Health Inc.'s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2022)

Amended and Restated Employment Agreement between Aspira Womens Health Inc. and Valerie B. Palmieri effective March 1, 2022 (Filed With SEC on February 28, 2022)

Employment Agreement between Aspira Womens Health Inc. and Nicole Sandford effective March 1, 2022 (Filed With SEC on February 28, 2022)

Consulting Agreement, dated March 25, 2021, by and between David Schreiber and Aspira Womens Health Inc (Filed With SEC on May 14, 2021)

Description of Aspira Women's Health Inc.'s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2021)

Underwriting Agreement, dated February 4, 2021, between Aspira Womens Health Inc. and William Blair & Company, L.L.C. and Truist Securities, Inc., as representatives of the... (Filed With SEC on February 8, 2021)

Securities Purchase Agreement, dated July 1, 2020, among Aspira Womens Health Inc. and the investors listed on Schedule I thereto (Filed With SEC on July 7, 2020)

Promissory Note, dated May 1, 2020, by and between Vermillion, Inc. and BBVA USA (Filed With SEC on May 7, 2020)

Description of Vermillion, Inc.s Securities Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on April 7, 2020)

Amended and Restated Promissory Note #1 by Vermillion, Inc. in favor of the State of Connecticut, acting by and through the Department of Economic and Community Development,... (Filed With SEC on April 7, 2020)

Amended and Restated Promissory Note #2 by Vermillion, Inc. in favor of the State of Connecticut, acting by and through the Department of Economic and Community Development,... (Filed With SEC on April 7, 2020)

Second Amendment to the Assistance Agreement by and between the State of Connecticut, acting by and through the Department of Economic and Community Development and Vermillion,... (Filed With SEC on April 7, 2020)

Amendment No. 4 to Testing and Services Agreement, executed as of March 11, 2020 by and among Vermillion, Inc., ASPiRA LABS, Inc. and Quest Diagnostics Incorporated (Filed With SEC on March 17, 2020)

Underwriting Agreement, dated June 26, 2019, between Vermillion, Inc. and William Blair & Company, L.L.C., as Underwriter (Filed With SEC on June 28, 2019)

VERMILLION, INC. 2019 STOCK INCENTIVE PLAN (Filed With SEC on June 24, 2019)

Form of Vermillion, Inc.s Stock Option Award (Filed With SEC on March 28, 2019)

Form of Vermillion, Inc.s Restricted Stock Award (Filed With SEC on March 28, 2019)

VERMILLION, INC. SECOND AMENDED AND RESTATED 2010 STOCK INCENTIVE PLAN (as amended effective June 21, 2018) ———————————————— Plan Document... (Filed With SEC on June 27, 2018)

10,000,000 Shares Vermillion, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 17, 2018)

50,000Shares Vermillion, Inc. Series B Convertible Preferred Stock UNDERWRITING AGREEMENT (Filed With SEC on April 17, 2018)

VERMILLION, INC. CERTIFICATE OF DESIGNATIONS, PREFERENCES AND RIGHTS OF SERIES B CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW (Filed With SEC on April 17, 2018)

First Amendment to the Assistance Agreement by and between the State of Connecticut, acting by and through the Department of Economic and Community Development and Vermillion,... (Filed With SEC on March 13, 2018)

AMENDMENT NO. 3 TO TESTING AND SERVICES AGREEMENT (Filed With SEC on March 6, 2018)

Exhibit 10.1 (Filed With SEC on December 20, 2017)

Exhibit 10.2 (Filed With SEC on December 20, 2017)

VERMILLION, INC. 12117 BEE CAVES ROAD, BUILDING THREE, SUITE 100 AUSTIN, TEXAS 78738 (Filed With SEC on August 28, 2017)

AMENDMENT NO. 2 TO TESTING AND SERVICES AGREEMENT (Filed With SEC on March 13, 2017)

ASSISTANCE AGREEMENT BY AND BETWEEN THE STATE OF CONNECTICUT ACTING BY THE DEPARTMENT OF ECONOMIC AND COMMUNITY DEVELOPMENT (An Equal Opportunity Employer) AND VERMILLION, INC. (Filed With SEC on May 16, 2016)

PROMISSORY NOTE (Filed With SEC on May 16, 2016)

PATENT SECURITY AGREEMENT (Filed With SEC on May 16, 2016)

SECURITY AGREEMENT (Filed With SEC on May 16, 2016)

CONSULTING AGREEMENT (Filed With SEC on March 30, 2016)

VERMILLION, INC. 8,350,000 Shares Common Stock ($0.001 par value) Underwriting Agreement (Filed With SEC on July 17, 2015)

VERMILLION, INC. SECOND AMENDED AND RESTATED 2010 STOCK INCENTIVE PLAN ———————————————— Plan Document... (Filed With SEC on June 22, 2015)

GLOBAL SETTLEMENT AGREEMENT AND MUTUAL RELEASE (Filed With SEC on May 12, 2015)

TESTING AND SERVICES AGREEMENT (Filed With SEC on May 12, 2015)

AMENDMENT NO. 1 TO TESTING AND SERVICES AGREEMENT (Filed With SEC on May 12, 2015)

NON-EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on May 12, 2015)

Exhibit 10.1 (Filed With SEC on April 6, 2015)

CONSULTING AGREEMENT (Filed With SEC on March 31, 2015)

Exhibit 10.1 (Filed With SEC on January 13, 2015)

Exhibit 10.1 (Filed With SEC on August 21, 2014)

EMPLOYMENT AGREEMENT (As Amended and Restated, Effective as of April 23, 2014) (Filed With SEC on August 14, 2014)

CONFIDENTIAL SEPARATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 14, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on May 15, 2014)

CONSULTING AGREEMENT (Filed With SEC on March 31, 2014)

VERMILLION, INC. AMENDED AND RESTATED 2010 STOCK INCENTIVE PLAN ———————————————— Plan Document ———————————————— (Filed With SEC on December 17, 2013)

Exhibit 10.1 (Filed With SEC on December 17, 2013)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 14, 2013)

STOCKHOLDERS AGREEMENT (Filed With SEC on May 14, 2013)

CONSULTING AGREEMENT (Filed With SEC on March 20, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on March 13, 2013)

SEPARATION AGREEMENT AND RELEASE RECITALS (Filed With SEC on December 11, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on November 28, 2012)

CONSULTING AGREEMENT (Filed With SEC on November 28, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on April 10, 2012)

ASSET PURCHASE AGREEMENT BY AND BETWEEN Vermillion, Inc. as Purchaser, and Correlogic Systems, Inc. as Seller Dated as of November 8, 2011 TABLE OF CONTENTS (Filed With SEC on March 27, 2012)

SETTLEMENT AGREEMENT AND RELEASE (Filed With SEC on March 27, 2012)

CONSULTING AGREEMENT (Filed With SEC on November 9, 2011)

DEFINITIONS FOR PURPOSES OF THIS OFFER LETTER (Filed With SEC on September 26, 2011)

EXCLUSIVE DISTRIBUTION AGREEMENT (Filed With SEC on August 9, 2011)

CONSULTING AGREEMENT (Filed With SEC on August 9, 2011)

AMENDMENT NO.5 TO STRATEGIC ALLIANCE AGREEMENT (Filed With SEC on May 10, 2011)

Shares VERMILLION, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on February 2, 2011)

AMENDMENT NO. 4 TO STRATEGIC ALLIANCE AGREEMENT (Filed With SEC on November 12, 2010)

EMPLOYMENT AGREEMENT (Filed With SEC on September 30, 2010)

EMPLOYMENT AGREEMENT (Filed With SEC on April 22, 2010)

VERMILLION, INC. (Filed With SEC on February 12, 2010)

IN THE UNITED STATES BANKRUPTCY COURT FOR THE DISTRICT OF DELAWARE ) In re: ) Chapter 11 ) VERMILLION, INC.,1 ) Case No. 09-11091 (CSS) ) Debtor. ) Re: Docket Nos. 160, 175, 186,... (Filed With SEC on January 12, 2010)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on December 29, 2009)

$1,500,000.00 (Filed With SEC on October 21, 2009)

AMENDMENT TO STRATEGIC ALLIANCE AGREEMENT (Filed With SEC on October 21, 2009)

Entry Into a Material Definitive Agreement (Filed With SEC on December 17, 2008)

Exhibit No (Filed With SEC on November 19, 2008)

Entry into a Material Definitive Agreement (Filed With SEC on August 29, 2008)

Entry Into a Material Definitive Agreement (Filed With SEC on August 29, 2008)

Oppenheimer & Co. Inc. 125 Broad Street 16th Floor New York, NY 10014 Member of All Principal Exchanges (Filed With SEC on November 27, 2007)

Common stock offered by selling stockholders (Filed With SEC on November 27, 2007)

Current assets (Filed With SEC on November 14, 2007)

Separation Agreement and Release by and between Debra Young and Vermillion, Inc. dated November 1, 2007 (Filed With SEC on November 5, 2007)

Common stock offered by selling stockholders (Filed With SEC on September 27, 2007)

VERMILLION, INC. THIRD AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on September 12, 2007)

EXHIBIT NO (Filed With SEC on August 29, 2007)

EXHIBIT NO (Filed With SEC on July 12, 2007)

On January 5, 2007, Ciphergen Biosystems, Inc. (the Company) received the resignation of James P. Merryweather, the Executive Vice President, Sales & Marketing of the Company... (Filed With SEC on January 11, 2007)

CIPHERGEN BIOSYSTEMS, INC. (Filed With SEC on November 21, 2006)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 21, 2006)

Pro Forma Financial Information (Filed With SEC on November 14, 2006)

EXCHANGE AND REDEMPTION AGREEMENT (Filed With SEC on November 6, 2006)

CONSULTING AGREEMENT (Filed With SEC on March 23, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on March 17, 2006)

Dated 22September 2005 (Filed With SEC on March 17, 2006)

EMPLOYMENTAGREEMENT (Filed With SEC on December 21, 2005)

CIPHERGENBIOSYSTEMS, INC. SECONDAMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on October 4, 2005)

CIPHERGENBIOSYSTEMS, INC. AMENDMENTTO RIGHTS AGREEMENT (Filed With SEC on July 28, 2005)

STRATEGIC ALLIANCE AGREEMENT BETWEEN QUESTDIAGNOSTICS INCORPORATED AND CIPHERGENBIOSYSTEMS, INC. DATED: JULY 22, 2005 (Filed With SEC on July 28, 2005)

CIPHERGENBIOSYSTEMS, INC. STOCKPURCHASE AGREEMENT (Filed With SEC on July 28, 2005)

WARRANT ToPurchase Common Stock of CIPHERGENBIOSYSTEMS, INC. July 22, 2005 (Filed With SEC on July 28, 2005)

CREDIT AGREEMENT BY AND BETWEEN QUEST DIAGNOSTICS INCORPORATED AND CIPHERGEN BIOSYSTEMS, INC. (Filed With SEC on July 28, 2005)

PATENTSECURITY AGREEMENT (Filed With SEC on July 28, 2005)

SUMMARY PLAN DESCRIPTION Ciphergen Biosystems Inc. 401(k) Plan (Filed With SEC on March 22, 2005)

VOLUMEPURCHASE AGREEMENT (PURCHASER SIDE) (Filed With SEC on March 22, 2005)

ASSET PURCHASE AGREEMENT By and Between CIPHERGEN BIOSYSTEMS, INC. and PALL CORPORATION Dated as of October 27, 2004 (Filed With SEC on December 6, 2004)

CIPHERGEN BIOSYSTEMS, INC. 2000 STOCK PLAN (Filed With SEC on August 9, 2004)

EMPLOYMENTAGREEMENT (Filed With SEC on March 15, 2004)

AMENDMENT ONE TO DISTRIBUTOR LICENSE AGREEMENT (Filed With SEC on March 15, 2004)

CIPHERGENBIOSYSTEMS, INC. SHAREPURCHASE AGREEMENT DatedMay 28, 2003 TABLE OFCONTENTS (Filed With SEC on June 11, 2003)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 31, 2003)

FIRSTAMENDMENT TO THE JOINT VENTURE AGREEMENT (Filed With SEC on March 31, 2003)

SECOND AMENDMENT TO JOINT VENTURE AGREEMENT (Filed With SEC on March 31, 2003)

THIRD AMENDMENT TO THE JOINT VENTUREAGREEMENT (Filed With SEC on March 31, 2003)

Exhibit A (Filed With SEC on March 31, 2003)

L E A S E A G R E E M E N T made between Symbion CVR No. 10 36 97 03 Fruebjergvej 3, DK-2100 Copenhagen (hereinafter referred to as Symbion) and (Filed With SEC on March 31, 2003)

Term Sheet Service and Support Agreement Ciphergen Biosystems, Inc. (CBI) and Applied Biosystems/MDS SCIEX (ABI) (Filed With SEC on March 31, 2003)

STOCK PURCHASE AGREEMENT (Filed With SEC on November 14, 2002)

ASSETPURCHASE AGREEMENT Byand Between INVITROGENCORPORATION and CIPHERGENBIOSYSTEMS, INC. Datedas of June 25, 2001 (Filed With SEC on August 14, 2001)

Category

Industry

Companies

Contracts

VERMILLION, INC. Contracts & Agreements